Generic companies ask district court to dismiss Takeda competition claims

09-05-2017

Generic companies ask district court to dismiss Takeda competition claims

kadmy / iStockphoto.com

Four generic companies have pushed a district court to dismiss competition allegations against them, stating that the latest amendments made by American Sales Company in a class action complaint are “purely cosmetic” and add no new factual allegations.


Teva, Sun Pharmaceutical, Actavis, Mylan, patent, generics, competition, antitrust, generic companies,

LSIPR